You’re already running the study.

Live · counting down
00
Days
:
00
Hours
:
00
Minutes
:
00
Seconds

Make your voice count before the FDA decides.

Watch · NE1 study briefing

Add your experience →Free · Encrypted · About 3 minutes

N-of-1 research platform

Evidence used to belong to institutions. Now it belongs to everyone.

NE1 turns self-experimentation into real science — structured N-of-1 trials, group studies, and clinician-run protocols that pool into open, population-scale evidence. A full pipeline from personal experience to published proof.

THE 7 PEPTIDES UNDER REVIEW

  • BPC-157
  • KPV
  • TB-500
  • MOTs-C
  • DSIP / Emideltide
  • Semax
  • Epitalon

Used any of these? Your experience deserves to be in the record.

Every result from these peptides has scattered into forums, DMs, and private notes — and none of it has ever been pooled. That’s the real-world evidence this review is missing, and the time to add yours is running out.

  • 🔒Encrypted & de-identified — your name is never attached.
  • You decide what’s shared. Your data is never sold.
  • No judgment — null results and side effects count as much as the wins.
  • No real name required to start.

The protocol

How your experience becomes evidence.

Three steps turn your experience into evidence anyone can use.

01 / LOG

Log a real protocol

Capture the peptide, dose, route, timing, and your reason — the same structure a clinical trial would demand.

02 / TRACK

Track honest outcomes

Record what actually happened, including no effect and adverse events. Null results count here.

03 / POOL

Pool into open evidence

Your N-of-1 trial joins thousands of others into population-scale signals anyone can learn from.

Start with step one →Free · Encrypted · About 3 minutes

The bigger picture

Millions are already experimenting on themselves. The data is just evaporating. Yours doesn’t have to.

The clock is ticking — make your experience and data count now.

Add your experience →Free · Encrypted · About 3 minutes

Stay in the loop

Not ready to log yet? Get the study updates.

Drop your email and we’ll tell you when the review goes live and when new findings are published. No spam.